Delivery Order SPE2DB22D3010-SPE2DB24FP2SK
Award Date
6/28/24
Potential Completion Date
7/1/24
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the drug Mounjaro (7.5 mg/0.5 ml pen, 0.5 ml) to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $4,574.47, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and has an ultimate completion date of May 18, 2023. This contract does not have a set-aside designation, indicating it...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order for the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen. The contract has a ceiling value of $23,215.87 and an ultimate completion date of December 6, 2023. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a firm fixed-price arrangement and was awarded without any set-aside designations, indicating open...
This federal contract award is for delivery of the pharmaceutical product Mounjaro (7.5 mg/0.5 mL pen) to the Defense Logistics Agency (DLA). The $36,978.47 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 24, 2024, with a completion date of October 25, 2024. The contract is a delivery order, not associated with a set-aside designation, and is part of AmerisourceBergen's broader $999,999,999 Indefinite Delivery Contract (IDC)...
The federal contract award is for the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML, with a ceiling value of $2,263.75. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. This is a delivery order contract with a firm fixed price pricing type, and an ultimate completion date of November 27, 2024. The contract does not have a set-aside designation,...
This federal contract award is for the delivery of the pharmaceutical product Mounjaro 15 mg/0.5 ml pen, 0.5 ml, with a total ceiling value of $57,922.88. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order and has a firm fixed price pricing type, with an ultimate completion date of December 31, 2024. It is not designated as a...
This federal contract award is for the delivery of the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen (0.5 ml) to the Defense Logistics Agency (DLA). The award, valued at $1,052.00, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a firm fixed-price delivery order contract with an ultimate completion date of December 14, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products, with a ceiling value of $5,215.72. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of May 30, 2024. It is not designated as a set-aside...
This federal contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $7,136.28. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is February 21, 2025. The contract does not have a set-aside designation, indicating...
This federal contract award is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,156.00, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 6, 2024. The contract was not designated with a set-aside...
This federal contract award is for the delivery of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $7,365.76 and was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...